ID | 112987 |
Title Alternative | De novo CD 20‐negative diffuse large B‐cell lymphoma developed with sustained fever and markedly high C‐reactive protein level
CD20陰性DLBCL
|
Author |
Miyakami, Yuko
Tokushima University
Nakamura, Shingen
Tokushima University
Tokushima University Educator and Researcher Directory
KAKEN Search Researchers
Okamoto, Yasunobu
Tokushima University
Takahashi, Mamiko
Tokushima University
Iwasa, Masami
Tokushima University
Fujii, Shiro
Tokushima University
Tokushima University Educator and Researcher Directory
KAKEN Search Researchers
Miki, Hirokazu
Tokushima University
Tokushima University Educator and Researcher Directory
KAKEN Search Researchers
Uehara, Hisanori
Tokushima University
Tokushima University Educator and Researcher Directory
KAKEN Search Researchers
Abe, Masahiro
Tokushima University
Tokushima University Educator and Researcher Directory
KAKEN Search Researchers
|
Keywords | CD20
fever of unknown origin
diffuse large B-cell lymphoma
CRP
|
Content Type |
Journal Article
|
Description | A 68-year-old woman presented with sustained fever for more than 1 month and admitted due to hematemesis and systemic edema. Computed tomography scan revealed swelling of the cervical, paraaortic lymph nodes. Blood test results showed severe anemia, elevation of white blood cell count, elevation of liver enzyme and coagulopathy with high C-reactive protein. Biopsy of the right cervical lymph node showed proliferation of abnormal lymphoid cells with necrosis and hemorrhage, which are positive for CD79α, CD30, MUM‐1, and bcl‐6 and negative for CD20, CD5, CD10, ALK, CD38, CD138, and EBER. Gene rearrangement of immunoglobulin heavy chain was detected in tumor cells. Bone marrow aspiration showed tumor involvement. The patient was diagnosed with de novo CD20‐negative diffuse large B-cell lymphoma(DLBCL)stage IV B. Reduced CHOP therapy was performed under artificial respiration due to pulmonary edema and takotsubo cardiomyopathy. Although her general condition and high CRP levels temporarily improved, she died 47 days after admission due to rapid relapse. De novo CD20‐negative DLBCL was rare and presented with high CRP levels and rapid progression, and was thought to be clinically different from the existing DLBCL. It is imperative to elucidate molecular pathophysiology and establish new treatment strategy for de novo CD20‐negative DLBCL.
|
Journal Title |
Shikoku Acta Medica
|
ISSN | 00373699
|
NCID | AN00102041
|
Publisher | 徳島医学会
|
Volume | 74
|
Issue | 5-6
|
Start Page | 193
|
End Page | 200
|
Sort Key | 193
|
Published Date | 2018-12-25
|
EDB ID | |
FullText File | |
language |
jpn
|
TextVersion |
Publisher
|
departments |
Medical Sciences
University Hospital
|